|
시장보고서
상품코드
2149289
제대혈 은행 서비스 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)Cord Blood Banking Services Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
제대혈 은행 서비스 시장 성장요인
세계 제대혈 은행 서비스 시장 규모는 2025년 11억 8,000만 달러로 평가되며, 2026년 12억 4,000만 달러에서 2034년까지 20억 4,000만 달러로 성장하여, 예측 기간 동안 연평균 성장률(CAGR) 6.4%를 기록할 것으로 전망됩니다. 2025년에는 북미가 38.14%의 점유율을 차지하며 시장을 주도했습니다. 제대혈 은행 서비스에는 출산 후 제대와 태반에서 채취된 줄기세포가 풍부한 혈액의 채취, 운송, 처리, 검사, 극저온 보존, 보관 및 제공이 포함됩니다. 이 서비스는 민간, 공공 및 하이브리드형 은행 모델을 통해 제공되고 있습니다.
시장 성장은 조혈모세포 이식에서 제대혈의 활용이 정착되고 있는 점, 보호자의 인식 제고, 산부인과 병원의 참여, 장기 보존을 통한 지속적인 수익, 처리 기술의 향상, 그리고 관리 체제의 강화에 힘입어 뒷받침되고 있습니다. 주요 기업으로는 Cord Blood Registry(CBR), FamiCord AG, 산동 제대혈 뱅크, ViaCord 등이 있으며, 이들 기업은 신규 서비스 출시, 파트너십, 제휴 및 주산기 조직 관련 서비스 확충을 통해 사업을 확대하고 있습니다.
제대혈 은행 서비스 시장의 동향
정액제 보관 서비스와 폭넓은 서비스 패키지가 시장의 양상을 새롭게 바꾸고 있습니다. 각 제공업체는 연간 정액제, 다년 계약, 갱신 프로그램, 디지털 계정 관리, 그리고 제대혈과 제대 조직 세트 플랜을 점점 더 많이 활용하고 있습니다. 이러한 모델은 지속적인 수익을 창출하는 동시에 장기 극저온 보관의 중요성을 높이고 있습니다. 또한 각 제공업체는 전자적 보관 이력 기록, 검체 추적, 고객용 포털 및 품질 모니터링 시스템 강화에도 주력하고 있습니다.
시장 역학
촉진요인 : 이식 가능한 줄기세포 공급원에 대한 수요 증가가 시장 확장을 뒷받침하고 있습니다. 제대혈은 기증자에게 침습적인 시술을 가하지 않고 채취할 수 있으며, 사전에 보관해 두었다가 적절한 환자가 이식을 필요로 할 때 제공할 수 있습니다. 이러한 수요는 혈액암, 면역 질환, 유전성 대사 질환 및 기타 조혈계 질환에 의해 뒷받침되고 있습니다.
억제요인 : 민간 은행의 고비용과 향후 자가 사용에 대한 불확실성이 이용 확대를 저해하고 있습니다. 가족은 일반적으로 채취, 처리, 검사, 동결보존 및 장기 보존에 드는 비용을 부담해야 합니다. 또한 전문가들의 지침에 따르면, 보존된 단위가 미래의 치료에 반드시 적합하다고 볼 수만은 없다는 점도 강조되고 있습니다.
기회 : 다양한 공공 은행 및 하이브리드 은행의 재고 확대는 큰 성장 기회를 제공합니다. 인종적으로 다양한 집단의 대표성을 높임으로써 기증자 매칭 정확도가 향상되며, 산부인과 병원과의 제휴를 통해 채취 네트워크를 확대할 수 있습니다.
과제 : 규제 및 인구통계학적 압력 속에서 검체의 품질을 유지하는 것은 여전히 어려운 과제입니다. 혈액은행은 일부 성숙 시장에서 출생률 감소에 대응하는 동시에, 채취, 운송, 검사, 처리, 동결보존, 보관 및 임상 제공에 이르는 전 과정에 걸쳐 엄격한 관리를 유지해야 합니다.
세분화 분석
서비스별 : 접수된 모든 혈액 단위에는 장기 보존 및 모니터링 요건이 적용되므로, 보존 서비스가 주요 서비스 부문을 차지하고 있습니다. 이 부문은 연평균 성장률(CAGR) 5.2%로 성장할 것으로 예측됩니다.
은행 유형별 : 민간 은행이 가장 큰 점유율을 차지하고 있으며, 2026년에는 65.4%를 차지할 것으로 예측됩니다. 하이브리드 부문은 연평균 성장률(CAGR) 10.6%로 성장할 것으로 전망됩니다.
구성요소별 : 제대혈이 시장을 독점하고 있으며, 확립된 조혈모세포 이식 용도에 힘입어 2026년에는 76.2%의 점유율을 차지할 것으로 예측됩니다. 제대 조직은 연평균 성장률(CAGR) 9.3%로 성장할 것으로 예상됩니다.
용도별 : 암이 주요 용도를 차지하고 있으며, 2026년에는 40.1%를 차지할 것으로 예측됩니다. 면역 질환은 연평균 성장률(CAGR) 7.7%로 성장할 것으로 전망됩니다.
서비스 제공자별 : 민간 은행이 계속해서 주요 제공자 부문으로 자리매김할 것으로 보이며, 2026년에는 55.7%의 점유율을 차지할 것으로 예측됩니다. 한편, 하이브리드 은행은 연평균 성장률(CAGR) 10.4%로 성장할 것으로 전망됩니다.
제대혈 은행 서비스 시장의 지역별 전망
북미 : 이 지역은 2025년에 4억 5,000만 달러에 달했으며, 확립된 민간 은행 네트워크와 정기적인 보관료 수입에 힘입어 계속해서 주요 지역 시장으로서의 지위를 유지했습니다. 미국 시장은 2026년에 4억 3,000만 달러에 달할 것으로 예상되며, 전 세계 매출의 34.9%를 차지할 것으로 전망됩니다.
유럽 : 유럽 시장은 보관 계약 갱신, 가격 조정, 공급업체 통합 및 주산기 조직 서비스 확장에 힘입어 2026년에는 2억 1,000만 달러에 달하며, 연평균 성장률(CAGR) 6.2%로 성장할 것으로 예측됩니다.
아시아태평양 : 이 지역은 2026년에 4억 6,000만 달러에 달할 것으로 예측되며, 가장 빠르게 성장하는 지역 시장으로 자리매김하고 있습니다. 2026년 시장 규모는 중국이 2억 3,000만 달러, 인도가 7,000만 달러, 일본이 3,000만 달러에 달할 것으로 예측됩니다.
라틴아메리카 및 중동 및 아프리카 : 라틴아메리카는 2026년에 약 6,000만 달러에 달할 것으로 예상되며, GCC(걸프협력회의) 국가들은 약 3,000만 달러에 달할 것으로 예측됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제6장 북미의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제7장 유럽의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제8장 아시아태평양의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제9장 라틴아메리카의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제10장 중동 및 아프리카의 제대혈 은행 서비스 시장 분석, 인사이트, 예측, 2021-2034년
제11장 경쟁 분석
KSM 26.10.22Growth Factors of cord blood banking services Market
The global cord blood banking services market size was valued at USD 1.18 billion in 2025 and is projected to grow from USD 1.24 billion in 2026 to USD 2.04 billion by 2034, exhibiting a CAGR of 6.4% during the forecast period. North America dominated the market with a 38.14% share in 2025. Cord blood banking services include collection, transportation, processing, testing, cryogenic preservation, storage, and release of stem-cell-rich blood collected from the umbilical cord and placenta after childbirth. Services are provided through private, public, and hybrid banking models.
Market growth is supported by the established use of cord blood in hematopoietic stem cell transplantation, rising parental awareness, maternity-hospital participation, recurring long-term storage revenue, improved processing technologies, and stronger chain-of-custody systems. Leading companies include Cord Blood Registry (CBR), FamiCord AG, Shandong Cord Blood Bank, and ViaCord, which are expanding through service launches, partnerships, collaborations, and broader perinatal tissue offerings.
CORD BLOOD BANKING SERVICES MARKET TRENDS
Subscription-based storage and broader service packages are reshaping the market. Providers are increasingly using annual subscriptions, multi-year contracts, renewal programs, digital account management, and bundled cord blood and cord tissue packages. These models create recurring revenue while increasing the importance of long-term cryogenic storage. Providers are also strengthening electronic chain-of-custody records, sample tracking, customer portals, and quality-monitoring systems.
MARKET DYNAMICS
Driver: Rising demand for transplant-ready stem cell sources is supporting market expansion. Cord blood can be collected without an invasive donor procedure, stored in advance, and released when a suitable patient requires transplantation. Demand is supported by blood cancers, immune disorders, inherited metabolic diseases, and other blood-forming conditions.
Restraint: High private-banking costs and uncertainty regarding future personal use restrict adoption. Families must generally pay collection, processing, testing, cryopreservation, and long-term storage charges. Professional guidance also emphasizes that stored units may not necessarily be suitable for future treatment.
Opportunity: Expansion of diverse public and hybrid inventories provides significant growth opportunities. Greater representation of ethnically diverse populations can improve donor matching, while maternity-hospital partnerships can expand collection networks.
Challenge: Maintaining sample quality amid regulatory and demographic pressures remains challenging. Banks must maintain strict controls across collection, transportation, testing, processing, cryopreservation, storage, and clinical release while managing declining birth volumes in several mature markets.
SEGMENTATION ANALYSIS
By Services: Storage represented the leading service segment because every accepted unit generates long-term preservation and monitoring requirements. The analysis segment is projected to grow at a 5.2% CAGR.
By Bank Type: Private banking held the largest share and is projected to account for 65.4% in 2026. The hybrid segment is expected to grow at a 10.6% CAGR.
By Component: Cord blood dominated the market and is projected to hold a 76.2% share in 2026, supported by established hematopoietic transplantation applications. Cord tissue is projected to grow at a 9.3% CAGR.
By Application: Cancer represented the leading application and is projected to account for 40.1% in 2026. Immune disorders are expected to grow at a 7.7% CAGR.
By Service Provider: Private banks remained the leading provider segment, projected to hold a 55.7% share in 2026, while hybrid banks are projected to grow at a 10.4% CAGR.
CORD BLOOD BANKING SERVICES MARKET REGIONAL OUTLOOK
North America: The region reached USD 0.45 billion in 2025 and remained the dominant regional market, supported by established private banking networks and recurring storage payments. The U.S. market is projected to reach USD 0.43 billion in 2026, representing 34.9% of global revenue.
Europe: Europe is projected to reach USD 0.21 billion in 2026, growing at a 6.2% CAGR, supported by storage renewals, pricing adjustments, provider consolidation, and broader perinatal tissue services.
Asia Pacific: The region is projected to reach USD 0.46 billion in 2026 and is identified as the fastest-growing regional market. China is projected at USD 0.23 billion, India at USD 0.07 billion, and Japan at USD 0.03 billion in 2026.
Latin America and Middle East & Africa: Latin America is expected to reach approximately USD 0.06 billion in 2026, while the GCC is projected at approximately USD 0.03 billion.
COMPETITIVE LANDSCAPE
Major companies include Cord Blood Registry (CBR), FamiCord AG, Shandong Cord Blood Bank, ViaCord, Beijing Cord Blood Bank, LifeCell International, Guangdong Cord Blood Bank, Cryo-Cell International, Shanghai Cord Blood Bank, and Cordlife Group. Competition centers on regulatory compliance, processing quality, cryogenic infrastructure, hospital partnerships, pricing, geographic coverage, and long-term storage reliability.
KEY INDUSTRY DEVELOPMENTS
In June 2026, FamiCord signed a framework agreement with ArThec for tissue-engineering technologies. In February 2025, Vita 34 AG changed its corporate name to FamiCord AG. In January 2025, Singapore's Ministry of Health renewed Cordlife's cord blood and human-tissue banking licenses for one year and permitted operations to resume.
REPORT COVERAGE
The report covers market size and value, trends, drivers, restraints, opportunities, challenges, segmentation by services, bank type, component, application and service provider, regional analysis, competitive landscape, company profiles, technological developments, and industry developments.
CONCLUSION
The global cord blood banking services market is projected to increase from USD 1.18 billion in 2025 to USD 1.24 billion in 2026 and USD 2.04 billion by 2034, at a 6.4% CAGR. Rising demand for transplant-ready stem cells, recurring storage models, greater parental awareness, public inventory expansion, and technological improvements are supporting market development. However, private-banking costs, regulatory requirements, sample-quality management, demographic changes, and uncertainty regarding future personal use remain important considerations. Expansion of hybrid models, diverse public inventories, hospital partnerships, and broader perinatal tissue services will continue shaping the market through 2034.
Segmentation By Services, Bank Type, Component, Application, Service Provider, and Region
By Services
- Collection & Transportation
- Processing
- Analysis
- Storage
- Others
By Bank Type
- Private
- Public
- Hybrid
By Component
- Cord Blood
- Cord Tissue
By Application
- Cancer
- Genetic Disorders
- Blood Disorders
- Immune Disorders
- Metabolic Disorders
- Others
By Service Provider
- Private Banks
- Public Banks
- Hospital-Affiliated Banks
- Hybrid Banks
- Others
By Region
- North America (By Services, By Bank Type, By Component, By Application, By Service Provider, and By Country)
- U.S. (By Services)
- Canada (By Services)
- Europe (By Services, By Bank Type, By Component, By Application, By Service Provider, and By Country/Sub-region)
- Germany (By Services)
- U.K. (By Services)
- France (By Services)
- Spain (By Services)
- Italy (By Services)
- Scandinavia (By Services)
- Rest of Europe (By Services)
- Asia Pacific (By Services, By Bank Type, By Component, By Application, By Service Provider, and By Country/Sub-region)
- China (By Services)
- Japan (By Services)
- India (By Services)
- Australia (By Services)
- Southeast Asia (By Services)
- Rest of Asia Pacific (By Services)
- Latin America (By Services, By Bank Type, By Component, By Application, By Service Provider, and By Country/Sub-region)
- Brazil (By Services)
- Mexico (By Services)
- Rest of Latin America (By Services)
- Middle East & Africa (By Services, By Bank Type, By Component, By Application, By Service Provider, and By Country/Sub-region)
- GCC (By Services)
- South Africa (By Services)
- Rest of the Middle East & Africa (By Services)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Challenges
- 3.5. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025
- 4.2. Advancements in the Cord Blood Banking Services Market
- 4.3. New Service Launches, Key Players
- 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
5. Global Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Services
- 5.1.1. Collection & Transportation
- 5.1.2. Processing
- 5.1.3. Analysis
- 5.1.4. Storage
- 5.1.5. Others
- 5.2. Market Analysis, Insights and Forecast - By Bank Type
- 5.2.1. Private
- 5.2.2. Public
- 5.2.3. Hybrid
- 5.3. Market Analysis, Insights and Forecast - By Component
- 5.3.1. Cord Blood
- 5.3.2. Cord Tissue
- 5.4. Market Analysis, Insights and Forecast - By Application
- 5.4.1. Cancer
- 5.4.2. Genetic Disorders
- 5.4.3. Blood Disorders
- 5.4.4. Immune Disorders
- 5.4.5. Metabolic Disorders
- 5.4.6. Others
- 5.5. Market Analysis, Insights and Forecast - By Service Provider
- 5.5.1. Private Banks
- 5.5.2. Public Banks
- 5.5.3. Hospital-Affiliated Banks
- 5.5.4. Hybrid Banks
- 5.5.5. Others
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Services
- 6.1.1. Collection & Transportation
- 6.1.2. Processing
- 6.1.3. Analysis
- 6.1.4. Storage
- 6.1.5. Others
- 6.2. Market Analysis, Insights and Forecast - By Bank Type
- 6.2.1. Private
- 6.2.2. Public
- 6.2.3. Hybrid
- 6.3. Market Analysis, Insights and Forecast - By Component
- 6.3.1. Cord Blood
- 6.3.2. Cord Tissue
- 6.4. Market Analysis, Insights and Forecast - By Application
- 6.4.1. Cancer
- 6.4.2. Genetic Disorders
- 6.4.3. Blood Disorders
- 6.4.4. Immune Disorders
- 6.4.5. Metabolic Disorders
- 6.4.6. Other
- 6.5. Market Analysis, Insights and Forecast - By Service Provider
- 6.5.1. Private Banks
- 6.5.2. Public Banks
- 6.5.3. Hospital-Affiliated Banks
- 6.5.4. Hybrid Banks
- 6.5.5. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.1.1. By Services
- 6.6.2. Canada
- 6.6.2.1. By Services
- 6.6.1. U.S.
7. Europe Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Services
- 7.1.1. Collection & Transportation
- 7.1.2. Processing
- 7.1.3. Analysis
- 7.1.4. Storage
- 7.1.5. Others
- 7.2. Market Analysis, Insights and Forecast - By Bank Type
- 7.2.1. Private
- 7.2.2. Public
- 7.2.3. Hybrid
- 7.3. Market Analysis, Insights and Forecast - By Component
- 7.3.1. Cord Blood
- 7.3.2. Cord Tissue
- 7.4. Market Analysis, Insights and Forecast - By Application
- 7.4.1. Cancer
- 7.4.2. Genetic Disorders
- 7.4.3. Blood Disorders
- 7.4.4. Immune Disorders
- 7.4.5. Metabolic Disorders
- 7.4.6. Others
- 7.5. Market Analysis, Insights and Forecast - By Service Provider
- 7.5.1. Private Banks
- 7.5.2. Public Banks
- 7.5.3. Hospital-Affiliated Banks
- 7.5.4. Hybrid Banks
- 7.5.5. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.6.1. U.K.
- 7.6.1.1. By Services
- 7.6.2. Germany
- 7.6.2.1. By Services
- 7.6.3. France
- 7.6.3.1. By Services
- 7.6.4. Spain
- 7.6.4.1. By Services
- 7.6.5. Italy
- 7.6.5.1. By Services
- 7.6.6. Scandinavia
- 7.6.6.1. By Services
- 7.6.7. Rest of Europe
- 7.6.7.1. By Services
- 7.6.1. U.K.
8. Asia Pacific Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Services
- 8.1.1. Collection & Transportation
- 8.1.2. Processing
- 8.1.3. Analysis
- 8.1.4. Storage
- 8.1.5. Others
- 8.2. Market Analysis, Insights and Forecast - By Bank Type
- 8.2.1. Private
- 8.2.2. Public
- 8.2.3. Hybrid
- 8.3. Market Analysis, Insights and Forecast - By Component
- 8.3.1. Cord Blood
- 8.3.2. Cord Tissue
- 8.4. Market Analysis, Insights and Forecast - By Application
- 8.4.1. Cancer
- 8.4.2. Genetic Disorders
- 8.4.3. Blood Disorders
- 8.4.4. Immune Disorders
- 8.4.5. Metabolic Disorders
- 8.4.6. Others
- 8.5. Market Analysis, Insights and Forecast - By Service Provider
- 8.5.1. Private Banks
- 8.5.2. Public Banks
- 8.5.3. Hospital-Affiliated Banks
- 8.5.4. Hybrid Banks
- 8.5.5. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.6.1. Japan
- 8.6.1.1. By Services
- 8.6.2. Australia
- 8.6.2.1. By Services
- 8.6.3. China
- 8.6.3.1. By Services
- 8.6.4. India
- 8.6.4.1. By Services
- 8.6.5. Southeast Asia
- 8.6.5.1. By Services
- 8.6.6. Rest of Asia Pacific
- 8.6.6.1. By Services
- 8.6.1. Japan
9. Latin America Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Services
- 9.1.1. Collection & Transportation
- 9.1.2. Processing
- 9.1.3. Analysis
- 9.1.4. Storage
- 9.1.5. Others
- 9.2. Market Analysis, Insights and Forecast - By Bank Type
- 9.2.1. Private
- 9.2.2. Public
- 9.2.3. Hybrid
- 9.3. Market Analysis, Insights and Forecast - By Component
- 9.3.1. Cord Blood
- 9.3.2. Cord Tissue
- 9.4. Market Analysis, Insights and Forecast - By Application
- 9.4.1. Cancer
- 9.4.2. Genetic Disorders
- 9.4.3. Blood Disorders
- 9.4.4. Immune Disorders
- 9.4.5. Metabolic Disorders
- 9.4.6. Others
- 9.5. Market Analysis, Insights and Forecast - By Service Provider
- 9.5.1. Private Banks
- 9.5.2. Public Banks
- 9.5.3. Hospital-Affiliated Banks
- 9.5.4. Hybrid Banks
- 9.5.5. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.1.1. By Services
- 9.6.2. Mexico
- 9.6.2.1. By Services
- 9.6.3. Rest of Latin America
- 9.6.3.1. By Services
- 9.6.1. Brazil
10. Middle East & Africa Cord Blood Banking Services Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Services
- 10.1.1. Collection & Transportation
- 10.1.2. Processing
- 10.1.3. Analysis
- 10.1.4. Storage
- 10.1.5. Others
- 10.2. Market Analysis, Insights and Forecast - By Bank Type
- 10.2.1. Private
- 10.2.2. Public
- 10.2.3. Hybrid
- 10.3. Market Analysis, Insights and Forecast - By Component
- 10.3.1. Cord Blood
- 10.3.2. Cord Tissue
- 10.4. Market Analysis, Insights and Forecast - By Application
- 10.4.1. Cancer
- 10.4.2. Genetic Disorders
- 10.4.3. Blood Disorders
- 10.4.4. Immune Disorders
- 10.4.5. Metabolic Disorders
- 10.4.6. Others
- 10.5. Market Analysis, Insights and Forecast - By Service Provider
- 10.5.1. Private Banks
- 10.5.2. Public Banks
- 10.5.3. Hospital-Affiliated Banks
- 10.5.4. Hybrid Banks
- 10.5.5. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. GCC
- 10.6.1.1. By Services
- 10.6.2. South Africa
- 10.6.2.1. By Services
- 10.6.3. Rest of Middle East & Africa
- 10.6.3.1. By Services
- 10.6.1. GCC
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Cord Blood Registry (CBR) (CooperSurgical)
- 11.2.2. FamiCord AG
- 11.2.3. Shandong Cord Blood Bank
- 11.2.4. ViaCord (Revvity)
- 11.2.5. Beijing Cord Blood Bank
- 11.2.6. LifeCell International Pvt. Ltd.
- 11.2.7. Guangdong Cord Blood Bank
- 11.2.8. Cryo-Cell International, Inc.
- 11.2.9. Shanghai Cord Blood Bank
- 11.2.10. Cordlife Group Limited
